Prognostic Factors in Small Cell Lung Cancer: A New Prognostic Index in Korean Patients

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Oncology

• Publication date

  2011-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000323333PMID 21412014
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Survival of small-cell lung cancer and its determinants of outcome in Singapore.

  2007cited by this paper
• Prognostic factors of small cell lung cancer.

  2004cited by this paper
• Treatment options for small cell lung cancer

  2004cited by this paper
• [Prognostic factors in patients with small cell lung cancer].

  2004cited by this paper
• Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival.

  2003cited by this paper
• Classification and regression tree analysis in public health: Methodological review and comparison with logistic regression

  2003cited by this paper
• Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer.

  2003cited by this paper
• Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer--what limits limited disease?

  2002cited by this paper
• Prognostic factors in Greek patients with small cell lung cancer (SCLC). A Hellenic Cooperative Oncology Group study.

  2002cited by this paper
• The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up.

  2001cited by this paper
• Prognostic factors for patients with small cell lung carcinoma

  2000cited by this paper
• New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

  2000cited by this paper
• New guidelines to evaluate the response to treatment in solid tumors

  2000cited by this paper
• Predictive and prognostic factors in small cell lung cancer: current status.

  2000cited by this paper
• Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group.

  1999cited by this paper
• Prognostic factors of small-cell lung cancer in Okayama Lung Cancer Study Group Trials.

  1998cited by this paper
• Cyfra 21-1 as a marker of lung cancer.

  1998cited by this paper
• Pretreatment prognostic factors for survival in small-cell lung cancer: a new prognostic index and validation of three known prognostic indices on 341 patients.

  1997cited by this paper
• Prognostic factors and prognostic staging system for small cell lung cancer.

  1997cited by this paper
• Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres.

  1996cited by this paper
• Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission.

  1995cited by this paper
• Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission.

  1995cited by this paper
• Prognostic Factors in Small Cell Lung Cancer.

  1995cited by this paper
• Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients.

  1995cited by this paper
• Small cell lung cancer: analysis of factors influencing the response to treatment and survival.

  1994cited by this paper
• Cyfra 21–1 in Lung Cancer: Comparison with Cea, Ca 125, Scc and Nse Serum Levels

  1994cited by this paper
• Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.

  1993cited by this paper
• Small-cell carcinoma of the lung: derivation of a prognostic staging system.

  1991cited by this paper
• Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.

  1990cited by this paper
• Clinical and Serologic Markers of Stage and Prognosis in Small Cell Lung Cancer

  1990cited by this paper
• Clinical and serologic markers of stage and prognosis in small cell lung cancer. A multivariate analysis

  1990cited by this paper
• An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research.

  1990cited by this paper
• Prognosis at presentation of small cell carcinoma of the lung.

  1990cited by this paper
• Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients.

  1989cited by this paper
• Prognostic factors in patients with small-cell lung cancer: preliminary results from a large randomised study.

  1988cited by this paper
• Smoking and effect of chemotherapy in small cell lung cancer.

  1988cited by this paper
• Therapy of small cell lung cancer: a perspective on two decades of clinical research.

  1988cited by this paper
• Pretreatment prognostic factors and scoring system in 407 small‐cell lung cancer patients

  1987cited by this paper
• Use of carcinoembryonic antigen in small cell lung cancer prognostic value and relation to the clinical course 1

  1987cited by this paper
• Prognostic factors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiation.

  1986cited by this paper
• First-line therapy with VP-16 and cisplatin for small-cell lung cancer.

  1986cited by this paper
• Carcinoembryonic antigen: a useful prognostic marker in small-cell lung cancer.

  1985cited by this paper
• VP-16 and cisplatin as first-line therapy for small-cell lung cancer.

  1985cited by this paper
• Laboratory parameters as an alternative to performance status in prognostic stratification of patients with small cell lung cancer.

  1981cited by this paper
• Smoking abstinence and small cell lung cancer survival. An association.

  1980cited by this paper
• Prognostic factors for survival in patients with inoperable lung cancer.

  1980cited by this paper

• Serum CYFRA 21-1 Level as a Prognostic Marker for Extensive Disease Small Cell Lung Cancer

  2024cites this paper
• Low diffusion capacity predicts poor prognosis in extensive stage small cell lung cancer: a single-center analysis of 10 years

  2023cites this paper
• Five-Year Overall Survival and Prognostic Factors in Patients with Lung Cancer: Results from the Korean Association of Lung Cancer Registry (KALC-R) 2015

  2022cites this paper
• Small-Cell Lung Cancer Long-Term Survivor Patients: How to Find a Needle in a Haystack?

  2021cites this paper
• CASE REPORTS Long-term survivors of advanced and metastatic lung cancer

  2020cites this paper
• Clinical outcomes of extensive-stage small cell lung cancer patients treated with thoracic radiotherapy at different times and fractionations

  2020cites this paper
• Long-term survivors of advanced and metastatic lung cancer

  2019cites this paper
• Prognostic significance of standardised uptake value (SUVmax) measured on 18F‐fluorodeoxyglucose positron emission tomography/computed tomography in patients with small cell lung cancer

  2017cites this paper
• Peripheral-type small cell lung cancer is associated with better survival and higher frequency of interstitial lung disease.

  2017cites this paper
• Retrospective analysis of outcomes and prognostic factors of chemotherapy for small-cell lung cancer

  2016cites this paper
• Syndrome of Inappropriate Antidiuretic Hormone Secretion: A Poor Prognosis in Small-cell Lung Cancer.

  2016cites this paper
• Lung Cancer: Targets and Therapy

  2016cites this paper
• Refining Prognosis in Lung Cancer: A Report on the Quality and Relevance of Clinical Prognostic Tools

  2015cites this paper
• Myc protein expression correlates with MYC amplification in small‐cell lung carcinoma

  2015cites this paper
• Small steps of improvement in small-cell lung cancer (SCLC) within two decades: a comprehensive analysis of 484 patients.

  2014cites this paper
• Glycoprotein nonmetastatic B as a prognostic indicator in small cell lung cancer

  2014cites this paper
• The Clinical Impact of the Sum of the Maximum Standardized Uptake Value on the Pretreatment with 18F-FDG-PET/CT in Small-Cell Lung Cancer

  2013cites this paper
• Oncothermia with chemotherapy in the patients with small cell lung cancer

  2013cites this paper